AmerisourceBergen Top Management
ABCDelisted Stock | USD 191.45 1.55 0.80% |
AmerisourceBergen employs about 46 K people. The company is managed by 22 executives with a total tenure of roughly 179 years, averaging almost 8.0 years of service per executive, having 2090.91 employees per reported executive. Evaluation of AmerisourceBergen's management performance can provide insight into the firm performance.
Steven Collis CEO CEO and President Director and Member of Executive Committee |
James Cleary President Executive Vice President and Presidentident - MWI Veterinary Supply |
AmerisourceBergen |
AmerisourceBergen Management Team Effectiveness
The company has Return on Asset of 0.027 % which means that on every $100 spent on assets, it made $0.027 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.3366 %, implying that it generated $2.3366 on every 100 dollars invested. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.AmerisourceBergen Workforce Comparison
AmerisourceBergen is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 193,929. AmerisourceBergen totals roughly 46,000 in number of employees claiming about 24% of equities under Health Care industry.
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.01 %, which entails that for every 100 dollars of revenue, it generated $0.01 of operating income. AmerisourceBergen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AmerisourceBergen insiders, such as employees or executives, is commonly permitted as long as it does not rely on AmerisourceBergen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, AmerisourceBergen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Walgreens Boots Alliance Inc over a year ago Sale by Walgreens Boots Alliance Inc of 1320858 shares of AmerisourceBergen | ||
Walgreens Boots Alliance Inc over a year ago Sale by Walgreens Boots Alliance Inc of 275984 shares of AmerisourceBergen |
AmerisourceBergen Notable Stakeholders
An AmerisourceBergen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AmerisourceBergen often face trade-offs trying to please all of them. AmerisourceBergen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AmerisourceBergen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Steven Collis | CEO and President Director and Member of Executive Committee | Profile | |
James Cleary | Executive Vice President and Presidentident - MWI Veterinary Supply | Profile | |
Robert Mauch | Executive Vice President, Group President - Pharmaceutical Distribution & Strategic Global Sourcing | Profile | |
Bennett Murphy | Vice President Investor Relations | Profile | |
John Chou | Executive Vice President, Chief Legal Officer and Secretary | Profile | |
Gina Clark | Executive Vice President, Chief Communications & Administration Officer | Profile | |
Kathy Gaddes | Chief Human Resource Officer, Executive Vice President | Profile | |
Silvana Battaglia | Chief Human Resource Officer, Executive Vice President | Profile | |
Leslie Donato | Executive Vice President and Chief Strategy Officer | Profile | |
Lazarus Krikorian | Senior Vice President Principal Accounting Officer, Corporate Controller | Profile | |
Ornella Barra | Director | Profile | |
Richard Gochnauer | Independent Director | Profile | |
Lon Greenberg | Independent Director | Profile | |
Dennis Nally | Independent Director | Profile | |
Kathleen Hyle | Independent Director | Profile | |
Jane Henney | Lead Independent Director | Profile | |
Henry McGee | Independent Director | Profile | |
Michael Long | Independent Director | Profile | |
PharmD Mauch | Ex COO | Profile | |
Lonie Haynes | Senior Vice President Chief Diversity and Inclusion Officer | Profile | |
D Durcan | Independent Director | Profile | |
Elizabeth Campbell | Senior Vice President and Deputy General Counsel | Profile |
About AmerisourceBergen Management Performance
The success or failure of an entity such as AmerisourceBergen often depends on how effective the management is. AmerisourceBergen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AmerisourceBergen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AmerisourceBergen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AmerisourceBergen Corporation sources and distributes pharmaceutical products. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Amerisourcebergen operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 000 people.
Please note, the presentation of AmerisourceBergen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AmerisourceBergen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AmerisourceBergen's management manipulating its earnings.
AmerisourceBergen Workforce Analysis
Traditionally, organizations such as AmerisourceBergen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AmerisourceBergen within its industry.AmerisourceBergen Manpower Efficiency
Return on AmerisourceBergen Manpower
Revenue Per Employee | 5.2M | |
Revenue Per Executive | 10.8B | |
Net Income Per Employee | 36.2K | |
Net Income Per Executive | 75.8M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in AmerisourceBergen Stock
If you are still planning to invest in AmerisourceBergen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AmerisourceBergen's history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |